Xebio Co., Ltd. announced consolidated and non-consolidated earnings results for the year ended March 31, 2015. For the quarter, on consolidated basis, the company's net sales were JPY 53,052 million compared to JPY 54,360 million a quarter ago. Operating profit was JPY 464 million compared to JPY 967 million a quarter ago. Ordinary profit was JPY 834 million compared to JPY 1,181 million a quarter ago. Net profit was JPY 967 million compared to JPY 701 million a year ago.

For the year, on consolidated basis, the company reported net sales of JPY 210,672 million against JPY 204,779 million a year ago. Operating profit was JPY 5,654 million against JPY 12,295 million a year ago. Ordinary profit was JPY 6,432 million against JPY 12,985 million a year ago. Net profit was JPY 2,084 million against JPY 6,618 million a year ago. Cash provided by operating activities was JPY 7,424 million compared to JPY 12,385 million and capital expenditure was JPY 9,312 million compared to JPY 9,339 million for the last year. Profit before income tax was JPY 3,873 million.

For the year, on non-consolidated basis, the company reported net sales of JPY 138,657 million against JPY 142,154 million a year ago. Operating profit was JPY 4,106 million against JPY 11,028 million a year ago. Ordinary profit was JPY 4,889 million against JPY 11,893 million a year ago. Net profit was JPY 1,722 million against JPY 6,158 million a year ago. Capital expenditure was JPY 7,949 million compared to JPY 6,719 million for the last year.

For the fiscal year 2016 the company expects net sales of JPY 231,203 million, operating profit of JPY 9,437 million, ordinary profit of JPY 9,729 million and net profit of JPY 4,360 million.